Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Flow Chemistry Summit 2021

Bayan Takizawa's Biography

Bayan Takizawa, Chief Business Officer, CONTINUUS Pharmaceuticals, Inc.

Bayan Takizawa, is a cofounder and Chief Business Officer at CONTINUUS Pharmaceuticals, a spin off from the Novartis-MIT Center for Continuous Manufacturing that is leveraging a novel continuous manufacturing platform to develop and produce drugs faster, cheaper, and of better quality. Dr. Takizawa has helped the CONTINUUS team raise over $100 million through financing rounds, grants, and contracts with multiple commercial partners and government agencies. Prior to joining CONTINUUS, Bayan was a consultant at The Chartis Group, and advisory firm that provides strategic and operational support for hospitals and healthcare systems. He also previously worked at Actin Biomed, a healthcare investment firm, and Yale New Haven Hospital as a General Surgery and Urology resident. Bayan has an M.D. from Yale, an M.S. in Engineering Systems and M.B.A. from MIT, and a B.S. in Chemical Engineering from Cornell. He has multiple publications in peer-reviewed journals, and is an active member of the Massachusetts life sciences community.

Bayan Takizawa Image

Challenges and Benefits of Implementing Integrated Continuous Manufacturing (ICM) Beyond the Laboratory

Thursday, 30 September 2021 at 18:30

Add to Calendar ▼2021-09-30 18:30:002021-09-30 19:30:00Europe/LondonChallenges and Benefits of Implementing Integrated Continuous Manufacturing (ICM) Beyond the LaboratoryFlow Chemistry Summit 2021 in Boston, USABoston,

Recently, there has been increased interest in the application of continuous manufacturing to pharmaceuticals. The advantages are undeniable, as many other industries have evolved their production systems, enjoying the improved efficiencies and lower costs associated with continuous manufacturing. Pharma, conversely, has been slower to adapt, clinging to outdated batch methods and fragmented supply chains that are vulnerable to disruptions, which ultimately impact patient care. Fortunately, more and more companies are embracing continuous manufacturing, several receiving approvals of continuously produced drug products in recent years. This presentation will focus on some of the challenges in implementing continuous manufacturing in the pharma industry, but also show why change is imminent. Regulatory, quality, cultural, and other relevant factors will be discussed.

Add to Calendar ▼2021-09-30 00:00:002021-10-01 00:00:00Europe/LondonFlow Chemistry Summit 2021Flow Chemistry Summit 2021 in Boston, USABoston,